AnteoTech Limited (ADO.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 9.38 Million AUD | 74.94% |
| 2023 | 5.36 Million AUD | -64.87% |
| 2022 | 15.26 Million AUD | -35.53% |
| 2021 | 23.67 Million AUD | 505.68% |
| 2020 | 3.9 Million AUD | -18.01% |
| 2019 | 4.76 Million AUD | 6.65% |
| 2018 | 4.47 Million AUD | -90.24% |
| 2017 | 45.81 Million AUD | -12.78% |
| 2016 | 52.52 Million AUD | 774.68% |
| 2015 | 6 Million AUD | -21.67% |
| 2014 | 7.66 Million AUD | 134.08% |
| 2013 | 3.27 Million AUD | -37.15% |
| 2012 | 5.21 Million AUD | -28.47% |
| 2011 | 7.28 Million AUD | 322.77% |
| 2010 | 1.72 Million AUD | 29.36% |
| 2009 | 1.33 Million AUD | -61.63% |
| 2008 | 3.47 Million AUD | 77.28% |
| 2007 | 1.95 Million AUD | 2.62% |
| 2006 | 1.9 Million AUD | 160.72% |
| 2005 | 732.06 Thousand AUD | -78.69% |
| 2004 | 3.43 Million AUD | -31.82% |
| 2003 | 5.03 Million AUD | -36.8% |
| 2002 | 7.97 Million AUD | -30.85% |
| 2001 | 11.52 Million AUD | 45.32% |
| 2000 | 7.93 Million AUD | 0.86% |
| 1999 | 7.86 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 7.4 Million AUD | 0.0% |
| 2024 FY | 9.38 Million AUD | 74.94% |
| 2024 Q4 | 9.38 Million AUD | 0.0% |
| 2023 Q4 | 5.36 Million AUD | 0.0% |
| 2023 Q2 | 11.68 Million AUD | 0.0% |
| 2023 FY | 5.36 Million AUD | -64.87% |
| 2022 FY | 15.26 Million AUD | -35.53% |
| 2022 Q4 | 15.26 Million AUD | 0.0% |
| 2022 Q2 | 20.66 Million AUD | 0.0% |
| 2021 Q2 | 6.98 Million AUD | 0.0% |
| 2021 FY | 23.67 Million AUD | 505.68% |
| 2021 Q4 | 23.67 Million AUD | 0.0% |
| 2020 FY | 3.9 Million AUD | -18.01% |
| 2020 Q2 | 3.97 Million AUD | 0.0% |
| 2020 Q4 | 3.9 Million AUD | 0.0% |
| 2019 Q2 | 2.98 Million AUD | 0.0% |
| 2019 Q4 | 4.76 Million AUD | 0.0% |
| 2019 FY | 4.76 Million AUD | 6.65% |
| 2018 Q2 | 5.34 Million AUD | 0.0% |
| 2018 FY | 4.47 Million AUD | -90.24% |
| 2018 Q4 | 4.47 Million AUD | 0.0% |
| 2017 Q4 | 45.81 Million AUD | 0.0% |
| 2017 Q2 | 52.08 Million AUD | 0.0% |
| 2017 FY | 45.81 Million AUD | -12.78% |
| 2016 Q2 | 9.53 Million AUD | 0.0% |
| 2016 FY | 52.52 Million AUD | 774.68% |
| 2016 Q4 | 52.52 Million AUD | 0.0% |
| 2015 FY | 6 Million AUD | -21.67% |
| 2015 Q2 | 7.66 Million AUD | 0.0% |
| 2015 Q4 | 6 Million AUD | 0.0% |
| 2014 Q2 | 7.95 Million AUD | 0.0% |
| 2014 FY | 7.66 Million AUD | 134.08% |
| 2014 Q4 | 7.66 Million AUD | 0.0% |
| 2013 Q3 | 3.27 Million AUD | -28.09% |
| 2013 Q2 | 4.55 Million AUD | 0.0% |
| 2013 Q1 | 4.55 Million AUD | -12.59% |
| 2013 FY | 3.27 Million AUD | -37.15% |
| 2013 Q4 | 3.27 Million AUD | 0.0% |
| 2012 FY | 5.21 Million AUD | -28.47% |
| 2012 Q4 | 5.21 Million AUD | 0.0% |
| 2011 FY | 7.28 Million AUD | 322.77% |
| 2011 Q4 | 7.28 Million AUD | 0.0% |
| 2010 Q4 | 1.72 Million AUD | 0.0% |
| 2010 FY | 1.72 Million AUD | 29.36% |
| 2009 FY | 1.33 Million AUD | -61.63% |
| 2009 Q4 | 1.33 Million AUD | 0.0% |
| 2008 FY | 3.47 Million AUD | 77.28% |
| 2008 Q4 | 3.47 Million AUD | 0.0% |
| 2007 Q4 | 1.95 Million AUD | 0.0% |
| 2007 FY | 1.95 Million AUD | 2.62% |
| 2006 FY | 1.9 Million AUD | 160.72% |
| 2006 Q4 | 1.9 Million AUD | 0.0% |
| 2005 Q4 | 732.06 Thousand AUD | 0.0% |
| 2005 FY | 732.06 Thousand AUD | -78.69% |
| 2004 Q4 | 3.43 Million AUD | 0.0% |
| 2004 FY | 3.43 Million AUD | -31.82% |
| 2003 FY | 5.03 Million AUD | -36.8% |
| 2003 Q4 | 5.03 Million AUD | 0.0% |
| 2002 FY | 7.97 Million AUD | -30.85% |
| 2002 Q4 | 7.97 Million AUD | 0.0% |
| 2001 Q4 | 11.52 Million AUD | 0.0% |
| 2001 FY | 11.52 Million AUD | 45.32% |
| 2000 FY | 7.93 Million AUD | 0.86% |
| 1999 FY | 7.86 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | -68.333% |
| Acrux Limited | 8.96 Million AUD | -4.666% |
| Actinogen Medical Limited | 21.31 Million AUD | 55.981% |
| Argenica Therapeutics Limited | 16.37 Million AUD | 42.719% |
| Arovella Therapeutics Limited | 13.28 Million AUD | 29.383% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -461.269% |
| Alterity Therapeutics Limited | 19.22 Million AUD | 51.2% |
| Amplia Therapeutics Limited | 14.84 Million AUD | 36.806% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -28.17% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -196.911% |
| Biome Australia Limited | 8.27 Million AUD | -13.343% |
| Biotron Limited | 493.47 Thousand AUD | -1801.041% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 91.659% |
| BTC Health Limited | 5.14 Million AUD | -82.201% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | 38.577% |
| CSL Limited | 56.93 Billion AUD | 99.984% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 93.933% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 95.941% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -11.837% |
| Dimerix Limited | 32.07 Million AUD | 70.756% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 63.286% |
| Hexima Limited | 2.26 Million AUD | -313.449% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -265.813% |
| Immuron Limited | 15.54 Million AUD | 39.671% |
| Immutep Limited | 147.44 Million AUD | 93.638% |
| Imugene Limited | 151.39 Million AUD | 93.804% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -53.286% |
| Memphasys Limited | 12.43 Million AUD | 24.529% |
| Nanollose Limited | 241.95 Thousand AUD | -3777.306% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 96.217% |
| Noxopharm Limited | 6.78 Million AUD | -38.289% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -72.579% |
| Nyrada Inc. | 5.9 Million AUD | -58.808% |
| Orthocell Limited | 26.61 Million AUD | 64.753% |
| PharmAust Limited | 11.12 Million AUD | 15.674% |
| Patrys Limited | 4.16 Million AUD | -125.424% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 65.75% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | 13.737% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 53.998% |
| PYC Therapeutics Limited | 91.23 Million AUD | 89.718% |
| Race Oncology Limited | 20.22 Million AUD | 53.624% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 86.977% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -47.28% |
| Starpharma Holdings Limited | 36.81 Million AUD | 74.517% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 97.645% |
| Tissue Repair Ltd | 19.38 Million AUD | 51.617% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -80.984% |